Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-08

FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for mycophenolate mofetil (generic) submitted by Mylan Pharmaceuticals, granting approval under an ANDA (ANDA065520) for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

SUPPL AP for MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)